Loading data
RKTONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 5.95 m USD | 3.25 m USD | 3.74 m USD | 4.93 m USD | 7.35 m USD |
| Operating profit | -12.36 m USD | -8.22 m USD | -7.95 m USD | -11.07 m USD | -14.1 m USD |
| Net income (reported basis) | -12.47 m USD | -8.19 m USD | -8.11 m USD | -11.36 m USD | -14.31 m USD |
| Net income attributable to common shareholders | — | — | -7.85 m USD | -11.37 m USD | -14.28 m USD |
| Basic earnings per share | -0.9 USD/share | -1.28 USD/share | -2.38 USD/share | -9.5 USD/share | -16.02 USD/share |
| Diluted earnings per share | -0.9 USD/share | -1.28 USD/share | -2.38 USD/share | -9.5 USD/share | -16.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.